1. Alzforum. (2017). High-dose Gantenerumab lowers plaque load. Available from: URL: https://www.alzforum.org/news/conference-coverage/high-dose-gantenerumab-lowers-plaque-load.
2. Alzforum. (2019). Donanemab. Available from: URL: https://www.alzforum.org/therapeutics/donanemab.
3. Alzforum. (2020). In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned. Available from: URL: https://www.alz-forum.org/news/conference-coverage/dian-tu-gantenerumab-brings-down-tau-lot-open-extension-planned.
4. Ancoli-Israel, S., Palmer, B.W., Cooke, J.R., Corey-Bloom, J., Fiorentino, L., Natarajan, L., Liu, L., Ayalon, L., He, F., and Loredo, J.S. (2008). Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: A randomized controlled study. J Am Geriatr Soc 56, 2076–2081.
5. Andrade, A.G., Bubu, O.M., Varga, A.W., and Osorio, R.S. (2018). The relationship between obstructive sleep apnea and Alzheimer’s Disease. J Alzheimers Dis 64, S255–S270.